Structural Characterization of Monoclonal Antibodies - The author describes techniques that can be used to provide the analytical data required by ICH Q6B for characterization of monoclonal

ADVERTISEMENT

Structural Characterization of Monoclonal Antibodies
The author describes techniques that can be used to provide the analytical data required by ICH Q6B for characterization of monoclonal antibodies.


BioPharm International Supplements
Volume 24, Issue 8, pp. s15-s22

SPECTROSCOPIC PROFILES


Figure 4: Raw data obtained from near ultraviolet (UV) analysis of a mAb.
The EMA and ICH guidelines also recommend that the higher-order structure of the mAb should be characterized by appropriate physicochemical methodologies. ICH Q6B recommends the use of "circular dichroism, nuclear magnetic resonance (NMR), or other suitable techniques, as appropriate." Today, circular dichroism (CD) analysis is commonly used to assess the secondary structure of mAbs. The data obtained from CD analysis of a mAb is shown in Figure 4. Assessment of the raw data using CDsstr software allows the relative percentages of the various secondary structures to be estimated as shown in Table I.


Table I: The result of CDSSTR algorithm assessment of the near UV CD (circular dichroism) data shown in Figure 4.
In addition to the structural characterization requirements outlined above, a number of additional physicochemical properties need to be assessed.

MOLECULAR WEIGHT OR SIZE


Figure 5: Deconvoluted mass spectrum obtained from online electrospray mass spectrometric detection (quantitative time-of-flight) LC/ES–MS (Q-TOF) analysis of a mAb.
On-line LC/ES–MS analysis of intact and reduced mAbs using quadrupole time-of-flight (Q–TOF) instrumentation has revolutionized the measurement of the intact molecular weight of mAbs and the released light and heavy chains. The data obtained from intact molecular weight analysis of a mAb using this technique is shown in Figure 5.


Figure 6A: Deconvoluted mass spectrum obtained from online LC/ES-MS (Q–TOF) analysis of a mAb.
The major peaks observed are 162 mass units apart which is consistent with variation in galactosylation of the N-linked oligosaccharides present on the heavy chains of the molecule. The mass spectrometric data obtained from analysis of the mAb following reduction are shown in Figure 6.


Figure 6B: Deconvoluted mass spectrum obtained from online LC/ES–MS (Q–TOF) analysis of a mAb following reduction.
The signal shown in Figure 6A is consistent with that expected for the light chain and the signals observed in Figure 6B are consistent with those expected for the heavy chain with the expected N-linked oligosaccharides. Aside from confirming the molecular weight of a mAb and the component light and heavy chains, these data also confirm the intactness of the protein backbones.


blog comments powered by Disqus

ADVERTISEMENT

Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
May 13, 2013
Amgen Forms New Joint Venture to Commercialize Vectibix in China
May 13, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International Supplements,
Click here